| Healing & Growth | |
|
2887 N Lake Pleasant Rd Attica MI 48412-9007 | |
| (810) 721-2941 | |
| Not Available |
| Full Name | Healing & Growth |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 2887 N Lake Pleasant Rd, Attica, Michigan |
| Authorized Official Name and Position | Maureen M Marunczak (OWNER) |
| Authorized Official Contact | 8105290221 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Healing & Growth 2887 N Lake Pleasant Rd Attica MI 48412-9007 Ph: (810) 721-2941 | Healing & Growth 2887 N Lake Pleasant Rd Attica MI 48412-9007 Ph: (810) 721-2941 |
| NPI Number | 1609498252 |
|---|---|
| Provider Enumeration Date | 05/16/2020 |
| Last Update Date | 01/05/2021 |
| Certification Date | 12/28/2020 |
| Medicare PECOS PAC ID | 9537572854 |
|---|---|
| Medicare Enrollment ID | O20210106000651 |
News Archive
Novo Nordisk has been awarded a Good Design Award(TM) for NovoTwist(TM), the new needle designed for use with the insulin delivery device FlexPen(R). The needle, which has a simple 'just twist' attachment and detachment, makes injection easier for people with diabetes.
In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.
The N.J. effort must secure federal approval first. Also in Medicaid news, a judge in California this week will hear arguments in the challenge to the state's plans for adult health care.
Researchers at Wake Forest Baptist Medical Center have successfully tested a prototype conducted electrical weapon (CEW) capable of recording a subject's heart rate and rhythm while still delivering incapacitating electrical charges.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609498252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
News Archive
Novo Nordisk has been awarded a Good Design Award(TM) for NovoTwist(TM), the new needle designed for use with the insulin delivery device FlexPen(R). The needle, which has a simple 'just twist' attachment and detachment, makes injection easier for people with diabetes.
In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.
The N.J. effort must secure federal approval first. Also in Medicaid news, a judge in California this week will hear arguments in the challenge to the state's plans for adult health care.
Researchers at Wake Forest Baptist Medical Center have successfully tested a prototype conducted electrical weapon (CEW) capable of recording a subject's heart rate and rhythm while still delivering incapacitating electrical charges.
› Verified 5 days ago